| Bioactivity | (Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor, and has the potential of reducing the secretion of gastric acid. | ||||||||||||
| Target | CCK-B receptor | ||||||||||||
| Invitro | (Rac)-Sograzepide is an antagonist of CCK-B receptor, and has the potential of reducing the secretion of gastric acid[1]. | ||||||||||||
| Name | (Rac)-Sograzepide | ||||||||||||
| CAS | 168161-71-5 | ||||||||||||
| Formula | C28H30N6O3 | ||||||||||||
| Molar Mass | 498.58 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Hamish Ryder, et al. Benzodiazepin derivatives useful as cck-receptor antagonists. WO 1993016999 A1. |
(Rac)-Sograzepide
CAS: 168161-71-5 F: C28H30N6O3 W: 498.58
(Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor, and has the potential of reducing the secretio
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.